Researchers at Johns Hopkins show pencil-tip robots that deliver antibiotics directly to infected heart tissue, potentially trimming weeks of therapy to hours.
Researchers at Johns Hopkins are testing tiny magnetic robots that could change how heart infections are treated. The two-part system uses a needle-like piece to anchor near the infection and a drug-carrying partner that attaches and releases antibiotics directly at the site.
Why it matters: endocarditis is costly and difficult to treat with current antibiotics, which often lose potency before they reach the heart. If this approach works in humans, it could shorten weeks of therapy to minutes or a few hours.
Researchers are testing a new way to treat heart infections that could dramatically shorten hospital stays and recovery time. Johns Hopkins engineers have designed two tiny magnetic devices, each about the size of a pencil tip, that work together to deliver antibiotics directly to infected heart tissue. The approach aims to bypass many of the challenges that blunt the effectiveness of conventional antibiotic therapy.
Endocarditis, an infection of the heart’s inner lining or valves, affects tens of thousands of people each year. The current standard usually requires several weeks of IV antibiotics, with doctors sometimes facing limited drug access to the heart and systemic side effects. The new method uses a pair of micro-sized teammates. A needle-like module anchors near the infection site and acts as a docking station. A second module, loaded with antibiotics, attaches magnetically to the needle and releases the drug where it’s needed. The collaboration allows repeated dosing without invasive surgery.
Crucially, neither robot carries a battery or motor. External magnetic coils generate precise fields that guide the devices from outside the body, similar in principle to how certain imaging devices steer equipment in medical tests. This external control could reduce tissue disruption and lower the chances of drug loss before it reaches the heart tissue.
In experiments using heart models and pig heart tissue, the duo demonstrated stability against blood flow and the ability to stay positioned long enough to deliver the medicine. The researchers say a single session could last around 10 minutes for one delivery and could require about an hour for multiple rounds. If the technique passes further testing, clinicians might perform a set of quick visits rather than a lengthy antibiotic course, potentially compressing weeks of therapy into a much shorter treatment window.
Looking ahead, the team plans to test the system in more lifelike heart models that beat and contract like real hearts. They’re also considering trials with other drugs, including cancer therapies, to see if the same mechanism can target different diseased tissues. The work appears in a study from Advanced Materials Technologies led by Johns Hopkins engineers.
Beyond the bedside implications, the research helps illustrate a broader trend in medicine: pairing miniature devices with smart steering to deliver drugs exactly where they’re needed, reducing systemic exposure and side effects. If successful, patients could benefit from shorter hospital stays and fewer days tethered to an IV drip, while doctors gain a new tool for stubborn heart infections that are difficult to treat with standard antibiotics.
This is an incredible form by @AIatMeta pic.twitter.com/fTcUKkvnqu
— Digital Trends (@DigitalTrends) October 12, 2026
You're reading the quick version.
A fresh NASA Landsat 9 image reveals an oval, legged impact site in the Kimberley region and hints at an ancient meteorite event.
A WHO report says the exact cause of a Russian infectious disease researcher’s death remains unconfirmed, with no sign of ongoing transmission yet uncertainty about exposure.
A new wave of spaceflight plans aims to put bases on the moon, but safety, cost and logistics could slow the push.
The Daily Brief
Every morning, the news that matters from AI, phones, apps and the people shaping tech. Explained in plain English. Free.
One email a day. No spam, unsubscribe anytime. Privacy policy
